Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Crinetics Pharmaceuticals (CRNX) over the last 8 years, with Q3 2025 value amounting to 0.0.

  • Crinetics Pharmaceuticals' Asset Utilization Ratio rose 1132.11% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year increase of 1132.11%. This contributed to the annual value of 0.0 for FY2024, which is 8764.8% down from last year.
  • Per Crinetics Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.0 for Q3 2025, which was up 1132.11% from 0.0 recorded in Q2 2025.
  • Over the past 5 years, Crinetics Pharmaceuticals' Asset Utilization Ratio peaked at 0.02 during Q2 2023, and registered a low of 0.0 during Q1 2025.
  • In the last 5 years, Crinetics Pharmaceuticals' Asset Utilization Ratio had a median value of 0.01 in 2023 and averaged 0.01.
  • As far as peak fluctuations go, Crinetics Pharmaceuticals' Asset Utilization Ratio soared by 93978.7% in 2021, and later crashed by 9090.82% in 2024.
  • Crinetics Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then surged by 234.09% to 0.01 in 2022, then plummeted by 51.1% to 0.01 in 2023, then tumbled by 86.06% to 0.0 in 2024, then surged by 40.98% to 0.0 in 2025.
  • Its Asset Utilization Ratio was 0.0 in Q3 2025, compared to 0.0 in Q2 2025 and 0.0 in Q1 2025.